Dafadine-ADAF-9 cytochrome P450 inhibitor CAS# 1065506-69-5 |
- Icotinib Hydrochloride
Catalog No.:BCC1639
CAS No.:1204313-51-8
- WZ8040
Catalog No.:BCC1075
CAS No.:1214265-57-2
- AZD-9291
Catalog No.:BCC4120
CAS No.:1421373-65-0
- PD168393
Catalog No.:BCC1157
CAS No.:194423-15-9
- Pelitinib (EKB-569)
Catalog No.:BCC1118
CAS No.:257933-82-7
- AZD8931 (Sapitinib)
Catalog No.:BCC3734
CAS No.:848942-61-0
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 1065506-69-5 | SDF | Download SDF |
PubChem ID | 24790866 | Appearance | Powder |
Formula | C23H25N3O3 | M.Wt | 391.46 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | DMSO : 50 mg/mL (127.73 mM; Need ultrasonic) | ||
Chemical Name | [5-[(2,6-dimethylphenoxy)methyl]-1,2-oxazol-3-yl]-(4-pyridin-4-ylpiperidin-1-yl)methanone | ||
SMILES | CC1=C(C(=CC=C1)C)OCC2=CC(=NO2)C(=O)N3CCC(CC3)C4=CC=NC=C4 | ||
Standard InChIKey | WNSNPYIHDMIFOO-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C23H25N3O3/c1-16-4-3-5-17(2)22(16)28-15-20-14-21(25-29-20)23(27)26-12-8-19(9-13-26)18-6-10-24-11-7-18/h3-7,10-11,14,19H,8-9,12-13,15H2,1-2H3 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Dafadine-A Dilution Calculator
Dafadine-A Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.5545 mL | 12.7727 mL | 25.5454 mL | 51.0908 mL | 63.8635 mL |
5 mM | 0.5109 mL | 2.5545 mL | 5.1091 mL | 10.2182 mL | 12.7727 mL |
10 mM | 0.2555 mL | 1.2773 mL | 2.5545 mL | 5.1091 mL | 6.3863 mL |
50 mM | 0.0511 mL | 0.2555 mL | 0.5109 mL | 1.0218 mL | 1.2773 mL |
100 mM | 0.0255 mL | 0.1277 mL | 0.2555 mL | 0.5109 mL | 0.6386 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
Dafadine-A is a small-molecule and novel inhibitor of DAF-9 cytochrome P450 (CYP27A1) [1].
Dafadine-A has been reported to induce loss of function of DAF-9 and alteration in the ligand-binding domain of DAF-12 in mammalian.. It can inhibit the enzymatic activity of DAF-9 in cells. The production of dafachronic acids was antagonized by dafadine-A. The absorbance spectroscopy studies showed that dafadine-A altered the difference spectrum of microsome-associated DAF-9 with a type 2 spectrum. These results suggested that dafadine-A is physically tethered to the catalytic center of the DAF-9. [1].
References:
[1]. Luciani GM1, Magomedova L, Puckrin R, Urbanus ML, Wallace IM, Giaever G, Nislow C, Cummins CL, Roy PJ. Dafadine inhibits DAF-9 to promote dauer formation and longevity of Caenorhabditis elegans. Nat Chem Biol. 2011 Nov 6;7(12):891-3.
- Ganodermanontriol
Catalog No.:BCN5872
CAS No.:106518-63-2
- Ganoderiol A
Catalog No.:BCN8158
CAS No.:106518-61-0
- Boldenone cyclopentanepropionate
Catalog No.:BCC8894
CAS No.:106505-90-2
- Boc-D-Phenylalaninol
Catalog No.:BCC2714
CAS No.:106454-69-7
- Korepimedoside A
Catalog No.:BCN7887
CAS No.:106441-31-0
- Acid Black 1
Catalog No.:BCC8806
CAS No.:1064-48-8
- Deoxymorellin
Catalog No.:BCN3067
CAS No.:1064-34-2
- Boc-D-Valinol
Catalog No.:BCC2692
CAS No.:106391-87-1
- Boc-D-Alaninol
Catalog No.:BCC2727
CAS No.:106391-86-0
- ω-Conotoxin GVIA
Catalog No.:BCC5700
CAS No.:106375-28-4
- DAPTA
Catalog No.:BCC5909
CAS No.:106362-34-9
- Rufinamide
Catalog No.:BCC5078
CAS No.:106308-44-5
- SMND-309
Catalog No.:BCC1956
CAS No.:1065559-56-9
- 7-Amino-4-methylcoumarin-3-acetic acid
Catalog No.:BCN2562
CAS No.:106562-32-7
- Parstatin (human)
Catalog No.:BCC6041
CAS No.:1065755-99-8
- Parstatin (mouse)
Catalog No.:BCC6042
CAS No.:1065756-01-5
- Hederacolchiside A1
Catalog No.:BCN6553
CAS No.:106577-39-3
- 3,10-Dihydroxy-5,11-dielmenthadiene-4,9-dione
Catalog No.:BCN1633
CAS No.:106623-23-8
- Qingyangshengenin A
Catalog No.:BCN8126
CAS No.:106644-33-1
- Trachelosiaside
Catalog No.:BCN7743
CAS No.:106647-12-5
- Matairesinol 4'-O-beta-gentiobioside
Catalog No.:BCN2848
CAS No.:106647-14-7
- Boc-D-Lys-OH
Catalog No.:BCC3420
CAS No.:106719-44-2
- Olprinone
Catalog No.:BCC1820
CAS No.:106730-54-5
- GYY 4137 morpholine salt
Catalog No.:BCC7739
CAS No.:106740-09-4